Diagnostic assay device having an apparent non-signal line
View Patent ↗A test device and method for determining the presence or absence of one or more analytes in a fluid sample, the test device including a support or member bearing a mark thereon, and a matrix or member containing a capture zone. In operation, an observation area in the test device becomes transparent, thereby allowing the user to view a mark that is present on a support that is disposed beneath the observation area. Typically, the mark on the underlying support is configured as a minus (−) sign. In the absence of analyte in the sample, the test device presents a negative result as a minus (−) signal. In the presence of analyte in the sample, however, the mark operates in concert with a perpendicular test line on the observation area to present a positive result as a plus (+) signal that is visible to the user.
1. A test device for determining the presence or absence of an analyte in a fluid sample, the test device comprising a test strip comprising:
a) a support bearing a mark thereon;
b) one or more matrices in fluid flow contact with one another and positioned over the support, the one or more matrices comprising:
i) a sample receiving zone for applying a fluid sample suspected of comprising an analyte,
ii) a label zone comprising a detectable mobile labeled reagent selected to bind to the analyte, and
iii) an observation area comprising a capture zone comprising an immobilized capture reagent, wherein the labeled reagent produces a detectable signal in the capture zone that is related to the presence of analyte in the sample, and wherein the observation area comprises a material that is opaque in a dry state and transparent in a moist state;
and wherein the mark is detectable within the observation area when the observation area is in a moist state.
2. The test device of claim 1 , wherein the label zone and observation area comprise separate matrices in fluid-flow contact.
3. The test device of claim 1 , wherein the sample receiving zone, label zone and observation area comprise separate matrices in fluid-flow contact.
4. The test device of claim 1 , wherein:
c) the mark has a shape such that a first symbol is detectable within the observation area when the observation area is in a moist state, and
d) the capture zone has a shape such that, in the presence of the analyte in the sample, a second symbol is detectable, and detection of the first symbol taken together with detection of the second symbol indicates a positive result.
5. The test device of claim 4 , wherein in the absence of analyte in the sample, the detectable first symbol indicates a negative result.
6. The test device of claim 1 , wherein the observation area further comprises a control area spatially distinct from the capture zone.
7. The test device of claim 1 , wherein the matrix further comprises a control area having a control line that is spatially distinct from the observation area.
8. The test device of claim 7 , wherein the control area is a negative control area, a positive control area, an end of assay control area, or a combination thereof.
9. The test device of claim 1 , wherein the observation area comprises nitrocellulose.
10. The test device of claim 1 , wherein the observation area is laminated on a plastic backing material.
11. The test device of claim 1 , wherein the label zone comprises a labeled reagent that binds an analyte selected from the group consisting of a toxin, an organic compound, a protein, a peptide, a microorganism, a bacteria, a virus, an amino acid, a nucleic acid, a carbohydrate, a hormone, a steroid, a vitamin, a drug, an antibody, a hapten, and an aggregation or combination thereof.
12. The test device of claim 1 , wherein the label zone comprises a labeled reagent that binds an analyte selected from the group consisting of a heartworm antigen, human chorionic gonadotropin, influenza antigen, and streptococcus A.
13. A method of determining the presence or absence of an analyte in a fluid sample, comprising the steps of: a) contacting the sample receiving zone of the device of claim 1 with a fluid sample; and b) inspecting the observation area for analyte restrained in the capture zone, wherein the mark is detectable within the observation area when the observation area is in a moist state, and wherein the mark and the restrained labeled analyte are separately detectable.
14. The method of claim 1 wherein the analyte is human chorionic gonadotropin.
15. The method of claim 14 , wherein: a) the mark has a shape such that a first symbol is detectable within the observation area when the observation area is in a moist state, and b) the capture zone has a shape such that, in the presence of the analyte in the sample, a second symbol is detectable to indicate a positive result.
16. The method of claim 14 , wherein the observation area further comprises a defined control area spatially distinct from the capture zone.
17. The method of claim 14 , wherein the matrix further comprises a control area that is spatially distinct from the capture zone.